{"log_id": 4672486124073306833, "direction": 0, "words_result_num": 40, "words_result": [{"probability": {"variance": 0.005268, "average": 0.984395, "min": 0.60066}, "location": {"width": 602, "top": 145, "height": 49, "left": 181}, "words": "T成淋巴细胞样细胞核内DNA呈碎片样改变,从而导致细胞凋亡"}, {"probability": {"variance": 0.000265, "average": 0.995065, "min": 0.899522}, "location": {"width": 831, "top": 164, "height": 58, "left": 185}, "words": "本品在体外与顺铂产生剂量依赖性协同作用,但未观察到顺铂对 dfdctp的蓄积或DNA链"}, {"probability": {"variance": 0.003069, "average": 0.983187, "min": 0.661658}, "location": {"width": 829, "top": 195, "height": 54, "left": 186}, "words": "的断裂有影响。在体外试验中,本品对LX-1和CALU-6人肺异种移植瘤显示出与顺铂协同"}, {"probability": {"variance": 0, "average": 0.999788, "min": 0.999788}, "location": {"width": 30, "top": 195, "height": 28, "left": 1147}, "words": "准"}, {"probability": {"variance": 0.00816, "average": 0.963303, "min": 0.619249}, "location": {"width": 497, "top": 233, "height": 42, "left": 185}, "words": "抗肿瘤作用,但对NCI-H460和NCI-H520瘤作用很小"}, {"probability": {"variance": 1.9e-05, "average": 0.995064, "min": 0.987993}, "location": {"width": 84, "top": 274, "height": 25, "left": 229}, "words": "毒理研究"}, {"probability": {"variance": 0.006458, "average": 0.981971, "min": 0.484684}, "location": {"width": 791, "top": 277, "height": 52, "left": 228}, "words": "遗传毒性:体外小鼠淋巴瘤(L5178Y)试验中本品导致正向突变,在体小鼠微核试验"}, {"probability": {"variance": 0.000361, "average": 0.992934, "min": 0.909912}, "location": {"width": 830, "top": 304, "height": 54, "left": 190}, "words": "中表现出裂变作用。本品Ames试验、体内姊妹染色单体交换试验、体外染色体畸变试验结"}, {"probability": {"variance": 4.4e-05, "average": 0.996722, "min": 0.968694}, "location": {"width": 411, "top": 346, "height": 38, "left": 190}, "words": "果均为阴性,体外亦不导致程序外DNA合成"}, {"probability": {"variance": 8.2e-05, "average": 0.994533, "min": 0.95665}, "location": {"width": 789, "top": 359, "height": 51, "left": 233}, "words": "生殖毒性:雄性小鼠腹腔注射本品0.5mg/kg日(以体表面积计算,大约为人用量的"}, {"probability": {"variance": 7.4e-05, "average": 0.995834, "min": 0.955099}, "location": {"width": 833, "top": 385, "height": 54, "left": 189}, "words": "1700)可引起中度至重度精子生成低下、生育能力降低、着床数减少。本品对雄性小鼠的"}, {"probability": {"variance": 0.00436, "average": 0.973354, "min": 0.659211}, "location": {"width": 826, "top": 413, "height": 53, "left": 190}, "words": "生育能力无明显影响,但静脉注射本品1.5mg/kg日(以体表面积计算约为人用量的1/00"}, {"probability": {"variance": 0.008049, "average": 0.971925, "min": 0.506143}, "location": {"width": 832, "top": 440, "height": 54, "left": 190}, "words": "对母体产生毒性,静脉注射0.25mg/kg/日(以体表面积计算约为入用量的1/1300)时可见胎"}, {"probability": {"variance": 7.2e-05, "average": 0.995155, "min": 0.970766}, "location": {"width": 213, "top": 487, "height": 34, "left": 191}, "words": "仔毒性和胚胎死亡现象"}, {"probability": {"variance": 6e-06, "average": 0.997458, "min": 0.993232}, "location": {"width": 137, "top": 518, "height": 26, "left": 220}, "words": "【药代动力学】"}, {"probability": {"variance": 0.011287, "average": 0.960604, "min": 0.526595}, "location": {"width": 754, "top": 527, "height": 52, "left": 266}, "words": "根据国外文献,按1000mg/m2的剂量给药30min,立即达血浆峰浓度,范围10-40u"}, {"probability": {"variance": 0.014006, "average": 0.935222, "min": 0.483904}, "location": {"width": 817, "top": 564, "height": 55, "left": 194}, "words": "gml。终末半衰期:17min(介于1126min)。平均中央分布容积11L/m2(介于5-2L/m2)"}, {"probability": {"variance": 0.002824, "average": 0.97758, "min": 0.738997}, "location": {"width": 822, "top": 602, "height": 53, "left": 193}, "words": "平均稳态分布容积(Vss):17L/m2(介于9-30L/m2)。蛋白结合率可忽略且组织分布不广泛"}, {"probability": {"variance": 0.008259, "average": 0.960134, "min": 0.584935}, "location": {"width": 808, "top": 638, "height": 56, "left": 198}, "words": "平均总清除率为90L/h/m2(介于40-130L/h/m2),且女性的平均总清除率较男性约低30%"}, {"probability": {"variance": 0.000148, "average": 0.995585, "min": 0.935005}, "location": {"width": 834, "top": 676, "height": 54, "left": 195}, "words": "虽然如此,使用该推荐剂量,病人不必减少吉西他滨的剂量。尿药排泄:不到10%的药物"}, {"probability": {"variance": 0.009574, "average": 0.955644, "min": 0.577035}, "location": {"width": 383, "top": 726, "height": 41, "left": 197}, "words": "以原型经尿排泄。肾清除率:2-7L/hr/m"}, {"probability": {"variance": 0, "average": 0.999543, "min": 0.999543}, "location": {"width": 44, "top": 813, "height": 25, "left": 255}, "words": "代谢"}, {"probability": {"variance": 0.000611, "average": 0.991328, "min": 0.869192}, "location": {"width": 779, "top": 825, "height": 53, "left": 253}, "words": "吉西他滨在肝脏、肾、血液和其他组织中被胞苷脱氨酶快速代谢。吉西他滨在细胞内"}, {"probability": {"variance": 0.000814, "average": 0.982851, "min": 0.9011}, "location": {"width": 832, "top": 863, "height": 52, "left": 201}, "words": "代谢产生吉西他滨单体及其二、三磷酸盐( dfdcmp、 dfdcdp和 dfdctp),其中 dfdcdp、 dfdctp"}, {"probability": {"variance": 0.000143, "average": 0.996032, "min": 0.941937}, "location": {"width": 718, "top": 903, "height": 51, "left": 202}, "words": "被认为是有活性的。这些细胞内代谢物在血浆、尿中未曾检测出。主要代谢物2"}, {"probability": {"variance": 0, "average": 0.998864, "min": 0.998864}, "location": {"width": 18, "top": 905, "height": 20, "left": 999}, "words": "2"}, {"probability": {"variance": 0.039928, "average": 0.831774, "min": 0.470417}, "location": {"width": 96, "top": 965, "height": 21, "left": 202}, "words": "2’-dif1"}, {"probability": {"variance": 0.000272, "average": 0.991673, "min": 0.928886}, "location": {"width": 469, "top": 943, "height": 43, "left": 356}, "words": "ine(dFdU),在血浆和尿中均可检测出,且无活性"}, {"probability": {"variance": 0.017453, "average": 0.940226, "min": 0.352502}, "location": {"width": 780, "top": 976, "height": 50, "left": 256}, "words": "终端消除半衰期:0.7—12小时。按35-350mg/m/30min给药, dfdctp在细胞内浓度"}, {"probability": {"variance": 0.006419, "average": 0.971095, "min": 0.615157}, "location": {"width": 824, "top": 1012, "height": 55, "left": 203}, "words": "的递增与剂量线性相关,药物的稳态浓度为0.4-5μg/ml。吉西他滨血药浓度超过5μg/m"}, {"probability": {"variance": 0.000187, "average": 0.992791, "min": 0.949365}, "location": {"width": 473, "top": 1061, "height": 44, "left": 205}, "words": "时, dfdctp的浓度不再增加,表明已在细胞内饱和"}, {"probability": {"variance": 0.006401, "average": 0.978192, "min": 0.472484}, "location": {"width": 781, "top": 1126, "height": 55, "left": 260}, "words": "按照1000mg/m330min的剂量给药,输注结束后30min内吉西他滨的血药浓度可持续"}, {"probability": {"variance": 0.002394, "average": 0.981134, "min": 0.744558}, "location": {"width": 649, "top": 1170, "height": 51, "left": 207}, "words": "高于约5μg/ml:输注结束后1小时内,其血药浓度亦高于0.4μg/ml"}, {"probability": {"variance": 6.6e-05, "average": 0.990512, "min": 0.974429}, "location": {"width": 121, "top": 1263, "height": 28, "left": 264}, "words": "DFdU动力学:"}, {"probability": {"variance": 0.016554, "average": 0.937388, "min": 0.499476}, "location": {"width": 777, "top": 1277, "height": 56, "left": 263}, "words": "以剂量100mg/m2,输注30min,输注结束后3-15min时,血浆峰浓度:28-52ug/ml"}, {"probability": {"variance": 0.010906, "average": 0.963356, "min": 0.386581}, "location": {"width": 830, "top": 1313, "height": 60, "left": 213}, "words": "一周剂量谷浓度:0.07-1.12μg/ml,无明显积蓄。三相药时曲线端平均半衰期为5hr(介"}, {"probability": {"variance": 0.006257, "average": 0.962964, "min": 0.666626}, "location": {"width": 834, "top": 1352, "height": 60, "left": 212}, "words": "于33至84hr)。dFdU在母体药物中的组成:91-98%。平均中央分布容积:18E/m2(介于"}, {"probability": {"variance": 0.024885, "average": 0.904254, "min": 0.437922}, "location": {"width": 755, "top": 1381, "height": 72, "left": 217}, "words": "1111平均稳态分布容积(s):150L/m2(介于9628m"}, {"probability": {"variance": 0.006857, "average": 0.970625, "min": 0.502983}, "location": {"width": 699, "top": 1432, "height": 55, "left": 266}, "words": "组织分布广泛且平均表观清除率为2.5L/h/m2(介于1/h/m)。经尿排除"}, {"probability": {"variance": 2e-06, "average": 0.99819, "min": 0.996038}, "location": {"width": 109, "top": 1529, "height": 33, "left": 270}, "words": "总体清除率"}], "language": 3}